This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing the SURMOUNT-OSA phase 3 clinical trial of tirzepatide in patients with obstructive sleep apnea and obesity
Ticker(s): LLY, NVOWho's the expert?
Institution: University of Miami Sleep Disorders Center
- Board certified in Sleep Medicine and Neurology with Special Qualification in Child Neurology and the Medical Director of the Miami VA Healthcare system Sleep Disorders laboratory.
- Areas of expertise include sleep disorders following traumatic brain injury, sleep disturbances, headaches, sleep apnea, snoring, insomnia and narcolepsy.
- Clinicical research focus on sleep apnea and insomnia treatment adherence with an interest in the coexistence of sleep apnea and insomnia and how this complicates sleep disorders treatment.
Interview GoalThis call will feature a discussion on the current treatment landscape and the potential of tirzepatide for the treatment of obstructive sleep apnea and obesity along with an analysis of the SURMOUNT-OSA phase 3 clinical trial of tirzepatide.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
